About
Jaguar Health develops and commercializes plant-based prescription medicines that target gastrointestinal distress in humans and animals. Its human health activities include prescription drugs derived from botanical sources for symptoms like chronic diarrhea, and it supports research into expanded uses of its lead compounds through clinical programs. The company’s animal health efforts involve prescription therapies for gastrointestinal conditions in companion animals, including products conditionally approved for veterinary use. Jaguar Health also pursues partnerships and joint ventures to explore additional plant-derived medicines, and it manages sustainable sourcing programs for its botanical ingredients.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- San Francisco, US
Contact Information
Find more investors like Jaguar
Search Investors